CORRECTION: HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals (1-for-10 Reverse Stock Split) - Headline Earlier Published on 9th Aug
CORRECTION: HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals (1-for-10 Reverse Stock Split) - Headline Earlier Published on 9th Aug
更正：HC Wainwright＆Co.繼續爲Rigel Pharmaceuticals（1比10反向股票拆分）保持買入——標題於8月9日早前發佈
HC Wainwright & Co. analyst Joseph Pantginis maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy with 1-for-10 Reverse Stock Split.
HC Wainwright & Co.分析師Joseph Pantginis維持Rigel Pharmaceuticals（納斯達克：rigel pharmaceuticals）的買入評級，同時進行1比10的股票拆分。